Ignite Creation Date:
2025-12-25 @ 2:02 AM
Ignite Modification Date:
2026-01-06 @ 8:24 AM
Study NCT ID:
NCT02962960
Status:
COMPLETED
Last Update Posted:
2023-01-12
First Post:
2016-09-23
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study to Characterize the Pharmacokinetics, Pharmacodynamics, and Safety of Anifrolumab in Adult Type I Interferon Test High Systemic Lupus Erythematosus Subject With Active Skin Manifestations
Sponsor:
AstraZeneca
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-02-14
Start Date Type:
ACTUAL
Primary Completion Date:
2018-01-22
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-12-17
Completion Date Type:
ACTUAL
First Submit Date:
2016-09-23
First Submit QC Date:
None
Study First Post Date:
2016-11-15
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2019-07-11
Results First Submit QC Date:
None
Results First Post Date:
2019-12-18
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2018-09-18
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2022-12-19
Last Update Post Date:
2023-01-12
Last Update Post Date Type:
ACTUAL